Skip to main content
Weiter zur Homepage der Europäischen Kommission (öffnet in neuem Fenster)
Deutsch de
CORDIS - Forschungsergebnisse der EU
CORDIS
Inhalt archiviert am 2024-04-30

Non-conventional analgesics - novel non-peptidic antagonists of bradykinin

Ziel



Research objectives and content
The aims of this project are the design and synthesis of new non-conventional analgesics. Bradykinin, a peptide of nine aminoacid residues, is the most potent of the endogenous algogenic substances. Thus, antagonist of bradykinin have a great interest in the treatment and prevention of pain. Since peptidic antagonists are expensive and non-active orally, there is a great interest in the development I of non-peptidic antagonists.
The non-peptidic antagonists known until now will be theoretically studied to develop the basic pharmacophore. Then, new derivatives will be design to fullfil that pharmacophore and those derivatives l more interesting will be synthesized and characterized. Subsequently, the analgesic activity will be | evaluated by an experienced group from the Faculty of Medicine of the U. Complutense of Madrid (Spain). In a feed-back process the biological results will be incorporated into the design and synthesis steps to improve the analgesic response.
Training contents (objective, benefit and expected impact)
Training in molecular modeling and drug design will open new perspectives to the applicant (in a future job search). Moreover, training in synthesis and spectroscopy analysis (nmr, uv, etc.) is fundamental for an organic chemist.
Links with industry/industrial relevance (22)
Members of the research group have and have had contracts with different pharmaceutical companies.

Wissenschaftliches Gebiet (EuroSciVoc)

Programm/Programme

Thema/Themen

Aufforderung zur Vorschlagseinreichung

Daten nicht verfügbar

Finanzierungsplan

RGI - Research grants (individual fellowships)

Koordinator

Consejo Superior de Investigaciones Científicas
EU-Beitrag
Keine Daten
Adresse
3,Juan de la Cierva 3
28071 Madrid
Spanien
Gesamtkosten
Keine Daten

Beteiligte (1)